The genetic abnormalities in CRC are characterized by high-frequency mutations in key oncogenic and tumor suppressing genes, such as Kirsten Rat Sarcoma Viral Proto-Oncogene (KRAS), p53 and Adenomatous Polyposis Coli (APC) [5,6]. This evidence concerns the gene TP53 and colorectal carcinoma.